arrow
A

Asunción Mejías

st jude childrens research hospital
H指数:59
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beyond Efficacy: Policy, Delivery, and Equity Determinants of Long-Acting Monoclonal Antibody Uptake for Infant RSV Prevention—A WAidid Consensus Document

超越疗效:婴儿RSV预防长效单克隆抗体使用的政策、配送和公平性决定因素——WAidid共识文件

2026-08-300
OA
Blood Gene Expression Profiles for Early Identification of Sepsis in Children with Cancer and Episodes of Fever and Neutropenia

癌症伴发热中性粒细胞减少儿童中脓毒症的早期基因表达谱识别

2026-08-290
OAAI
Single-cell map of the healthy human immune system across the lifespan reveals unique infant immune signatures

单细胞图谱揭示健康人免疫系统的全生命周期独特婴儿免疫特征

2026-06-150
OAAI
B cell imprinting in children impairs antibodies to the haemagglutinin stalk

儿童的b细胞印迹会损害血凝素茎的抗体

Nature
IF48.5
2026-03-110
OAAI
Concordance of Pathogenic Bacteria in the Upper and Lower Airway in Children With Severe Viral Lower Respiratory Tract Infections

上呼吸道和下呼吸道病原菌的一致性在患有严重病毒性下呼吸道感染的儿童中。Pediatr. Infect. Dis. J

2026-03-012
PRE
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation

实现婴儿呼吸道合胞病毒预防公平化的路径:全球实施的挑战与机遇

2025-11-030
OAAI
Identifying Pediatric Long COVID: Comparing an EHR Algorithm to Manual Review

识别儿科长新冠:比较电子健康记录算法与人工审核

2025-10-010
OAAI
SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults' responses

SARS-CoV-2诱导的婴儿免疫扰动因疾病严重程度而异,且与成人的反应不同。

2025-05-160
OA
Altered nasal and oral microbiomes define pediatric sickle cell disease

改变的鼻腔和口腔微生物组定义了儿童镰状细胞病

MSPHERE
IF3.1
2025-05-140
OA
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children

二十五年来帕利珠单抗的应用:对其在全球范围内对儿童呼吸道合胞病毒疾病负担影响的回顾性研究

2025-04-010
OA
Age-associated differences in mucosal and systemic host responses to SARS-CoV-2 infection

年龄相关的黏膜和系统性宿主对SARS-CoV-2感染的应答差异

2025-03-100
OA